Decibel Therapeutics Inc (NASDAQ:DBTX)
| 4.28 Delayed Data As of Feb 08 |  +0.72 / +20.06%Today’s Change | 1.61 Today|||52-Week Range 5.78 | +108.78% Year-to-Date |
Latest DBTX News | Press Releases
No recent news for Decibel Therapeutics Inc.
Today’s Trading
| Previous close | 3.59 |
| Today’s open | 3.64 |
| Day’s range | 3.59 - 4.70 |
| Volume | 589,923 |
| Average volume (3 months) | 83,107 |
| Market cap | -- |
Data as of 3:59pm ET, 02/08/2023
Growth & Valuation
| Earnings growth (last year) | -976.70% |
| Earnings growth (this year) | +8.56% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 27, 2023 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$51.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
